Clinical trial · Interventional
Endoscopic Breast Surgery in Treating Patients With Breast Cancer
Endoscopic Breast Surgery Feasibility Study
NCT01222377CI-TRIAL-00013685terminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): P.I. left
Summary
Brief summary (as posted)
RATIONALE: Endoscopic breast surgery (EBS) is a less invasive type of surgery for breast cancer and may have fewer side effects and improve recovery. PURPOSE: This clinical trial studies endoscopic breast surgery in treating patients with breast cancer.
Conditions
Conditions (9)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Male Breast Cancer | Male Breast Carcinoma | ALIAS | 0.90 |
| Recurrent Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
| Stage IA Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
| Stage IB Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
| Stage II Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
| Stage IIIA Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
| Stage IIIB Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
| Stage IIIC Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
| Stage IV Breast Cancer | Malignant Breast Neoplasm |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| endoscopic surgery | Procedure | — | UNRESOLVED |
| quality-of-life assessment | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Arm I
- description
- Patients undergo endoscopic breast surgery.
- interventionNames
- Procedure: endoscopic surgery
- Procedure: quality-of-life assessment
Primary outcomes (1)
- measure
- To estimate the surgical complication rate among all patients having EBS and the local recurrence rate among patients with breast cancer
- timeFrame
- 5 years
Secondary outcomes (1)
- measure
- To evaluate the safety, breast cosmesis and patient quality of life following EBS
- timeFrame
- After completion of study treatment
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
Show eligibility criteria text
Inclusion Criteria: * Breast cancer or prophylactic mastectomy requiring axillary nodal staging * Breast disease (e.g., fibroadenoma, ADH) * Ability to read and/or comprehend consent form and questionnaires * Ability to follow-up per protocol * Not pregnant or breastfeeding Exclusion Criteria: * Pregnant or breastfeeding * Evidence of chest wall or skin\* involvement * NOTE: \*may be endoscopy-assisted
References
Publications (0)
Data not yet available
No reference posted for this study.